Last updated: 2026-09-06 22:45:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Coya Therapeutics, Inc. (COYA) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $4,75, with a market capitalization of $103,68M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $3,71 to $7,75. This page covers its latest market performance, valuation, price trends and company information.
$103,68M | |
$4,54 | |
$10,69 | |
$3,21 | |
$4,55 | |
73,01K | |
-- | |
-- | |
$7,75 | |
$3,71 | |
-- | |
-- |
Coya Therapeutics, Inc. (COYA) last closed at $4,55 as of 2026-09-04 23:31:00, unchanged from the previous close of $4,55.
During the latest regular trading session, COYA traded between $3,21 and $10,69, with a volume of 73,01K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, Coya Therapeutics, Inc. (COYA) moved from $4,58 to $4,75, representing a gain of 3,71% ($0,17).
The stock traded between $4,52 and $4,75 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 88,20 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 25,7%
COYA is currently trading at $4,75, placing it 25,7% of the way from its 52-week low of $3,71 to its 52-week high of $7,75. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (Tregs). The company's initial development programs are focused on neurodegenerative, chronic inflammatory, autoimmune, and metabolic diseases with high unmet medical needs.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 8 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Coya Therapeutics, Inc. (COYA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.